Bel'chenko D I, Khanina N Ia, Kalinkin M N
Vopr Med Khim. 1987 May-Jun;33(3):42-5.
Hyperlipoproteinemia, which was developed after intravenous administration of lipoprotein atherogenous fraction, caused the secondary metabolic alterations. These alterations were manifested as a decrease in catabolism of blood serum lipoproteins, accumulation of hydrophobic lipid components in the lipoproteins as well as in a decrease in relative content of high density lipoproteins responsible for elimination of cholesterol from tissues.